Lycobetaine acetate

Drugs of the Future

Volumn 22, Issue 2, 1997, Pages 123-129

  Xu, Bin ^a   Wang, Xing Wang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LYCOBETAINE ACETATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER; CELL LINE; DNA DAMAGE; DRUG SYNTHESIS; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; SHORT SURVEY; TUMOR CELL;

EID: 0030971488     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.02.393109     Document Type: Short Survey

References (26)

1. Zee-Cheng, R.K.Y., Yan, S.J., Cheng, C.C. Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction. J Med Chem 1978, 21: 199-203.
2. Owen, T.Y., Wang, S.Y., Chang, S.Y., Lu, F.L., Yang, C.L., Hsu, B. A new antitumor substance-lycobetaine (AT-1840). Kexue Tongbao (China) 1976, 21: 285-7.
3. Zhang, S.Y., Lu, F.L., Yang, J.L., Wang, L.J., Xu, B. Effect of lycobetaine acetate on animal tumors and its toxicity. Acta Pharmacol Sin 1981, 2: 41-5.
4. B cells. Acta Pharmacol Sin 1987, 8: 86-90.
5. Xu, B. The influence of several antitumor agents on cell proliferation, differentiation and the cell cycle of murine erythroleukemia cells. Amer J Chin Med 1982, 9: 268-76.
6. Zhang, S.Y., Dai, Z.Q., Shu, R.S., Xu, B. Effect of lycobetaine (AT-1840) on microstructure of mouse Ehrlich ascites carcinoma cells. Tumor (China) 1987, 7: 249-50.
7. Wang, Z.W., Shu, R.S., Xu, B. Nucleolus segregation of tumor cells induced by actinomycin K and lycobetaine. Acta Pharmacol Sin 1982, 3: 48-51.
8. Xu, B., Liu, J. Some achievements of biotechnology application in anticancer drug research in China. Acta Biotechnol 1990, 10: 485-90.
9. Liu, J., Yang, S.L., Xu, B. Effect of lycobetaine on chromatin structure and activity of mouse hepatoma cells. Science in China (Ser. B) 1990, 33: 1459-65.
10. Weisbrod, S. Active chromatin. Nature 1982, 297: 289-95.
11. Wu, H., Shen, C.Y., Xu, B. Effect of lycobetaine on DNA circular dichroism. Chin J Pharmacol Toxicol 1987, 1: 272-5.
12. Liu, J., Yang, S.L., Xu, B. Characteristics of the interaction of lycobetaine with DNA. Acta Pharmacol Sin 1989, 10: 437-42.
13. Zhou, P.Q., Xu, B. Influence of lycobetaine on the cell cycle and mitosis in mouse Ehrlich carcinoma cells. Chin Pharmacol Bull 1989, 5: 89-91.
14. Xu, B. Recent advances in pharmacologic study of natural antitumor agents in China. Med Inst Oswaldo Cruz, Rio de Janeiro 1991, 86(Suppl. II): 51-4.
15. Wu, H., Xu, B. Effect of lycobetaine on nuclear RNA polymerase activity in murine hepatoma cells. Abstracts of 5th Southeast Asia and West Pacific Regions Meeting of Pharmacologists, Beijing, 1988, p224.
16. Ambrose, E.J., James, A.M., Lowick, J.H.B. Difference between the electrical charge carried by normal and homologous tumor cells. Nature 1956, 177: 576-7.
17. Lin, Y.H., Xu, B. Studies on cell membrane and new antitumor drugs. Prog Physiol Sci (China) 1982, 13: 345-7.
18. Lu, D.Y., Xu, J., Xu, B., Zhou, A.M. Influence of several antineoplastic drugs on serum sialic acid of mice bearing tumors. Chin Biochem J 1993, 9: 626-30.
19. Jin, Y.F., Tong, L.M., Liang, H.Z., Cao, C.Y., Wang, J.F., Li, X.Y. Effect of lycobetaine acetate on immune responses of normal and tumor-bearing mice. Chin J Pharmacol Toxicol 1987, 1: 277-82.
20. Lu, D.Y., Xu, J., Chen, Y.F., Xu, B., Shen, Z.M., Lu, L.J. Effect of harringtonine on lymphocyte rossette formation and serum sialic acid level in mice bearing tumors. Acta Oncol Sin 1992, 2: 7-9.
21. Liang, G., Xu, Y.P., Xu, B. Pharmacokinetic study of lycobetaine. Acta Pharmacol Sin 1995, 16: 78.
22. Liang, G., Xu, Y.P., Xu, B. Pharmacokinetics of lycobetaine acetate. Chin Pharmacol Bull 1997, 13: 11-4.
23. Wang, X.W., Yue, X.F., Han, J.X., Wu, F.G., Shun, Z.M., Xu, B., Huang, C.C. Effect of three antitumor agents on the induction of sister chromatid exchange (SCE) in V79 cells and their cytotoxicity. Kexue Tongbao (China) 1984, 8: 505-8.
24. Fei, C., Liu, G.Z., Dong, M.G., Hua, Z.D., Wu, Q.F., Li, S.J., Hu, Z.Y. Clinical observation of lycobetaine for the treatment of ovarian carcinoma. New Drugs and Clinical Remedies (China) 1985, 4: 1-3.
25. Xu, B., Han, L., Pan, X.C. Progress of studies on tumor pharmacology in China. Chin Pharmacol Bull 1996, 12: 7-10.
26. Wang, X.W., Xu, B. Advances of studies on antitumor drugs in China. Bio/Pharm Q (USA) 1995, 1: 30-1.